Memantine
Memantine (Namenda) appears in two listed tablets, the named brand and Donamem. Both address cognitive symptoms associated with Alzheimer’s disease and dementia. Donamem adds donepezil, creating a combination formulation distinct from single-ingredient Namenda. Listed products differ in ingredient profile, form, strength, and pack size.
How does memantine work?
An NMDA receptor antagonist, memantine moderates excessive glutamate signalling involved in nerve-cell function. The tablets have recorded uses for Alzheimer’s Disease and dementia. Both belong to Neurology.
Important safety information for Memantine
Information about Memantine on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.